Search Results - "Aklillu, Eleni"

Refine Results
  1. 1
  2. 2

    Efficacy and safety of praziquantel and dihydroartemisinin piperaquine combination for treatment and control of intestinal schistosomiasis: A randomized, non-inferiority clinical trial by Mnkugwe, Rajabu Hussein, Minzi, Omary, Kinung'hi, Safari, Kamuhabwa, Appolinary, Aklillu, Eleni

    Published in PLoS neglected tropical diseases (01-09-2020)
    “…Background Despite the reported success in reducing morbidity, praziquantel alone is insufficient for the control and elimination of schistosomiasis, partly…”
    Get full text
    Journal Article
  3. 3

    Correlation of N-acetyltransferase 2 genotype and acetylation status with plasma isoniazid concentration and its metabolic ratio in ethiopian tuberculosis patients by Sileshi, Tesemma, Telele, Nigus Fikrie, Burkley, Victoria, Makonnen, Eyasu, Aklillu, Eleni

    Published in Scientific reports (15-07-2023)
    “…Unfavorable treatment outcomes for tuberculosis (TB) treatment might result from altered plasma exposure to antitubercular drugs in TB patients. The present…”
    Get full text
    Journal Article
  4. 4

    Prevalence and correlates of intestinal schistosomiasis infection among school-aged children in North-Western Tanzania by Mnkugwe, Rajabu Hussein, Minzi, Omary S, Kinung'hi, Safari M, Kamuhabwa, Appolinary A, Aklillu, Eleni

    Published in PloS one (05-02-2020)
    “…Schistosomiasis is a neglected tropical disease that continues to cause morbidity and mortality in Sub Saharan Africa. Due to its endemicity, co-infection with…”
    Get full text
    Journal Article
  5. 5

    Constitutive androstane receptor and pregnane X receptor genotype influence efavirenz plasma concentration and CYP2B6 enzyme activity by Petros, Zelalem, Habtewold, Abiy, Makonnen, Eyasu, Aklillu, Eleni

    Published in Scientific reports (11-06-2022)
    “…Efavirenz is metabolized by CYP2B6, an inducible enzyme whose expression is regulated by the constitutive androstane receptor and pregnane X receptor nuclear…”
    Get full text
    Journal Article
  6. 6

    The safety of a dolutegravir (DTG)-based antiretroviral treatment (ART) regimen for pregnancy and birth outcomes in Ethiopia: evidence from multicenter cohort study by Gedefaw, Abel, Tadesse, Birkneh Tilahun, Berhan, Yifru, Makonnen, Eyasu, Vella, Stefano, Aklillu, Eleni

    Published in BMC infectious diseases (02-09-2024)
    “…A dolutegravir (DTG)-based antiretroviral regimen has been rolled out for pregnant women in low- and middle-income countries since 2020. However, available…”
    Get full text
    Journal Article
  7. 7

    Optimal single sampling time-point for monitoring of praziquantel exposure in children by Mnkugwe, Rajabu Hussein, Ngaimisi Kitabi, Eliford, Kinung’hi, Safari, Kamuhabwa, Appolinary A. R., Minzi, Omary Mashiku, Aklillu, Eleni

    Published in Scientific reports (09-09-2021)
    “…Praziquantel pharmacokinetics studies in schistosomiasis infected children are scarce partly due to the challenges/complexity of intensive blood sampling in…”
    Get full text
    Journal Article
  8. 8

    Prevalence and predictors of glucose metabolism disorders among People Living with HIV on combination antiretroviral therapy by Tadesse, Wondmagegn Tamiru, Adankie, Birhanemeskel T, Shibeshi, Workineh, Amogne, Wondwossen, Aklillu, Eleni, Engidawork, Ephrem

    Published in PloS one (19-01-2022)
    “…We investigated prevalence and predictors of glucose metabolism disorders (GMDs) among People Living with HIV (PLWH) on efavirenz- and…”
    Get full text
    Journal Article
  9. 9

    Potential drug–drug interactions between antiretroviral therapy and treatment regimens for multi-drug resistant tuberculosis: Implications for HIV care of MDR-TB co-infected individuals by Mukonzo, Jackson, Aklillu, Eleni, Marconi, Vincent, Schinazi, Raymond F.

    “…•MDR-TB agents exhibit overlapping enzyme inhibition that might affect ART outcomes.•Clofazimine, a core MDR-TB drug, could be responsible for most DDIs with…”
    Get full text
    Journal Article
  10. 10

    Effect of pharmacogenetic variations on praziquantel plasma concentration and safety outcomes among school children in Rwanda by Barry, Abbie, Kabatende, Joseph, Telele, Nigus Fikrie, Mnkugwe, Rajabu Hussein, Mugisha, Michael, Ntirenganya, Lazare, Bienvenu, Emile, Aklillu, Eleni

    Published in Scientific reports (26-01-2023)
    “…School-based mass drug administration (MDA) of Praziquantel (PZQ) is the global intervention strategy for elimination of schistosomiasis. Genetic variations in…”
    Get full text
    Journal Article
  11. 11

    CYP2C19 and CYP2J2 genotypes predict praziquantel plasma exposure among Ethiopian school-aged children by Gebreyesus, Tigist Dires, Makonnen, Eyasu, Telele, Nigus Fikrie, Barry, Abbie, Mnkugwe, Rajabu Hussein, Gerba, Heran, Dahl, Marja-Liisa, Aklillu, Eleni

    Published in Scientific reports (22-05-2024)
    “…Metabolism of praziquantel (PZQ), a racemic mixture and the only drug approved to treat S. mansoni infection, is mediated by genetically polymorphic enzymes…”
    Get full text
    Journal Article
  12. 12

    Pregnancy Increases CYP3A Enzymes Activity as Measured by the 4β-Hydroxycholesterol/Cholesterol Ratio by Mlugu, Eulambius M, Minzi, Omary M, Kamuhabwa, Appolinary A R, Diczfalusy, Ulf, Aklillu, Eleni

    “…Changes in cortisol and other hormones during pregnancy may alter CYP3A enzymes activity, but data from sub-Saharan Africa are sparse. We investigated the…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Effect of Pharmacogenetics Variations on Praziquantel Plasma Concentrations and Schistosomiasis Treatment Outcomes Among Infected School-Aged Children in Tanzania by Mnkugwe, Rajabu Hussein, Minzi, Omary, Kinung’hi, Safari, Kamuhabwa, Appolinary, Aklillu, Eleni

    Published in Frontiers in pharmacology (31-08-2021)
    “…Studies on pharmacogenetics of praziquantel (PZQ) and its relevance on plasma drug concentrations and schistosomiasis treatment outcomes are lacking. We…”
    Get full text
    Journal Article
  15. 15

    Screening for latent tuberculosis in migrants—status quo and future challenges by Petersen, Eskild, Al-Abri, Seif, Al-Jardani, Amina, Memish, Ziad A., Aklillu, Eleni, Ntoumi, Francine, Mwaba, Peter, Wejse, Christian, Zumla, Alimuddin, Al-Yaquobi, Fatma

    “…•Latent tuberculosis infection (LTBI) is key to fulfilling the WHO “End tuberculosis” strategy by 2035.•This review summarizes existing data on screening and…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    Efficacy and safety of praziquantel preventive chemotherapy in Schistosoma mansoni infected school children in Southern Ethiopia: A prospective cohort study by Gebreyesus, Tigist Dires, Makonnen, Eyasu, Tadele, Tafesse, Mekete, Kalkidan, Gashaw, Habtamu, Gerba, Heran, Aklillu, Eleni

    Published in Frontiers in pharmacology (2023)
    “…The World Health Organization recommends efficacy and safety surveillance of anti-helminths used in mass drug administration campaigns. We evaluated the…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Pharmacogenetic & pharmacokinetic biomarker for efavirenz based ARV and rifampicin based anti-TB drug induced liver injury in TB-HIV infected patients by Yimer, Getnet, Ueda, Nobuhisa, Habtewold, Abiy, Amogne, Wondwossen, Suda, Akira, Riedel, Klaus-Dieter, Burhenne, Jürgen, Aderaye, Getachew, Lindquist, Lars, Makonnen, Eyasu, Aklillu, Eleni

    Published in PloS one (06-12-2011)
    “…Implication of pharmacogenetic variations and efavirenz pharmacokinetics in concomitant efavirenz based antiviral therapy and anti-tubercular drug induced…”
    Get full text
    Journal Article